PlainRecalls
FDA Devices Moderate Class II Ongoing

Citrasate Liquid Acid concentrate bottles, Product Code 08-2251-CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reported: January 20, 2021 Initiated: November 23, 2020 #Z-0834-2021

Product Description

Citrasate Liquid Acid concentrate bottles, Product Code 08-2251-CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.

Reason for Recall

The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.

Details

Units Affected
278 cases
Distribution
US Nationwide distribution.
Location
Waltham, MA

Frequently Asked Questions

What product was recalled?
Citrasate Liquid Acid concentrate bottles, Product Code 08-2251-CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.. Recalled by Fresenius Medical Care Holdings, Inc.. Units affected: 278 cases.
Why was this product recalled?
The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 20, 2021. Severity: Moderate. Recall number: Z-0834-2021.